[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States DNA Gyrase Subunit B (EC 5.99.1.3) Market Report 2018

March 2018 | 99 pages | ID: U62AF0D3581QEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States DNA Gyrase Subunit B (EC 5.99.1.3) market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of DNA Gyrase Subunit B (EC 5.99.1.3) in these regions, from 2013 to 2025 (forecast).
United States DNA Gyrase Subunit B (EC 5.99.1.3) market competition by top manufacturers/players, with DNA Gyrase Subunit B (EC 5.99.1.3) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Abgentis Limited
  • AstraZeneca Plc
  • Daiichi Sankyo Company Ltd
  • Merck & Co., Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • GYR-12
  • DS-2969
  • VXC-100
  • VT-12008911
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Bacterial Infections
  • Clostridium Diffclie Infections
  • Klebsiella Pneumoniae Infections
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States DNA Gyrase Subunit B (EC 5.99.1.3) Market Report 2018

1 DNA GYRASE SUBUNIT B (EC 5.99.1.3) OVERVIEW

1.1 Product Overview and Scope of DNA Gyrase Subunit B (EC 5.99.1.3)
1.2 Classification of DNA Gyrase Subunit B (EC 5.99.1.3) by Product Category
  1.2.1 United States DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 GYR-12
  1.2.4 DS-2969
  1.2.5 VXC-100
  1.2.6 VT-12008911
  1.2.7 Others
1.3 United States DNA Gyrase Subunit B (EC 5.99.1.3) Market by Application/End Users
  1.3.1 United States DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Bacterial Infections
  1.3.3 Clostridium Diffclie Infections
  1.3.4 Klebsiella Pneumoniae Infections
  1.3.5 Others
1.4 United States DNA Gyrase Subunit B (EC 5.99.1.3) Market by Region
  1.4.1 United States DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West DNA Gyrase Subunit B (EC 5.99.1.3) Status and Prospect (2013-2025)
  1.4.3 Southwest DNA Gyrase Subunit B (EC 5.99.1.3) Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic DNA Gyrase Subunit B (EC 5.99.1.3) Status and Prospect (2013-2025)
  1.4.5 New England DNA Gyrase Subunit B (EC 5.99.1.3) Status and Prospect (2013-2025)
  1.4.6 The South DNA Gyrase Subunit B (EC 5.99.1.3) Status and Prospect (2013-2025)
  1.4.7 The Midwest DNA Gyrase Subunit B (EC 5.99.1.3) Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of DNA Gyrase Subunit B (EC 5.99.1.3) (2013-2025)
  1.5.1 United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales and Growth Rate (2013-2025)
  1.5.2 United States DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Growth Rate (2013-2025)

2 UNITED STATES DNA GYRASE SUBUNIT B (EC 5.99.1.3) MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States DNA Gyrase Subunit B (EC 5.99.1.3) Average Price by Players/Suppliers (2013-2018)
2.4 United States DNA Gyrase Subunit B (EC 5.99.1.3) Market Competitive Situation and Trends
  2.4.1 United States DNA Gyrase Subunit B (EC 5.99.1.3) Market Concentration Rate
  2.4.2 United States DNA Gyrase Subunit B (EC 5.99.1.3) Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers DNA Gyrase Subunit B (EC 5.99.1.3) Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES DNA GYRASE SUBUNIT B (EC 5.99.1.3) SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales and Market Share by Region (2013-2018)
3.2 United States DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Market Share by Region (2013-2018)
3.3 United States DNA Gyrase Subunit B (EC 5.99.1.3) Price by Region (2013-2018)

4 UNITED STATES DNA GYRASE SUBUNIT B (EC 5.99.1.3) SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Market Share by Type (2013-2018)
4.3 United States DNA Gyrase Subunit B (EC 5.99.1.3) Price by Type (2013-2018)
4.4 United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Growth Rate by Type (2013-2018)

5 UNITED STATES DNA GYRASE SUBUNIT B (EC 5.99.1.3) SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales and Market Share by Application (2013-2018)
5.2 United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES DNA GYRASE SUBUNIT B (EC 5.99.1.3) PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Abgentis Limited
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 DNA Gyrase Subunit B (EC 5.99.1.3) Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 AstraZeneca Plc
  6.2.2 DNA Gyrase Subunit B (EC 5.99.1.3) Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Daiichi Sankyo Company Ltd
  6.3.2 DNA Gyrase Subunit B (EC 5.99.1.3) Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Merck & Co., Inc.
  6.4.2 DNA Gyrase Subunit B (EC 5.99.1.3) Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview

7 DNA GYRASE SUBUNIT B (EC 5.99.1.3) MANUFACTURING COST ANALYSIS

7.1 DNA Gyrase Subunit B (EC 5.99.1.3) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of DNA Gyrase Subunit B (EC 5.99.1.3)

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 DNA Gyrase Subunit B (EC 5.99.1.3) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of DNA Gyrase Subunit B (EC 5.99.1.3) Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES DNA GYRASE SUBUNIT B (EC 5.99.1.3) MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Volume, Revenue Forecast (2018-2025)
11.2 United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Volume Forecast by Type (2018-2025)
11.3 United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Volume Forecast by Application (2018-2025)
11.4 United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of DNA Gyrase Subunit B (EC 5.99.1.3)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (K Pcs) by Type (2013-2025)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Volume Market Share by Type (Product Category) in 2017
Figure GYR-12 Product Picture
Figure DS-2969 Product Picture
Figure VXC-100 Product Picture
Figure VT-12008911 Product Picture
Figure Others Product Picture
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of DNA Gyrase Subunit B (EC 5.99.1.3) by Application in 2017
Figure Bacterial Infections Examples
Table Key Downstream Customer in Bacterial Infections
Figure Clostridium Diffclie Infections Examples
Table Key Downstream Customer in Clostridium Diffclie Infections
Figure Klebsiella Pneumoniae Infections Examples
Table Key Downstream Customer in Klebsiella Pneumoniae Infections
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (Million USD) by Region (2013-2025)
Figure The West DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Share by Players/Suppliers
Figure 2017 United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Share by Players/Suppliers
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Players/Suppliers
Figure 2017 United States DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Players/Suppliers
Table United States Market DNA Gyrase Subunit B (EC 5.99.1.3) Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market DNA Gyrase Subunit B (EC 5.99.1.3) Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Market Share of Top 3 Players/Suppliers
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers DNA Gyrase Subunit B (EC 5.99.1.3) Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers DNA Gyrase Subunit B (EC 5.99.1.3) Product Category
Table United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales (K Pcs) by Region (2013-2018)
Table United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Share by Region (2013-2018)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Share by Region (2013-2018)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Region in 2017
Table United States DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Region (2013-2018)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Region (2013-2018)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Region in 2017
Table United States DNA Gyrase Subunit B (EC 5.99.1.3) Price (USD/Pcs) by Region (2013-2018)
Table United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales (K Pcs) by Type (2013-2018)
Table United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Share by Type (2013-2018)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Share by Type (2013-2018)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Type in 2017
Table United States DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Share by Type (2013-2018)
Figure Revenue Market Share of DNA Gyrase Subunit B (EC 5.99.1.3) by Type (2013-2018)
Figure Revenue Market Share of DNA Gyrase Subunit B (EC 5.99.1.3) by Type in 2017
Table United States DNA Gyrase Subunit B (EC 5.99.1.3) Price (USD/Pcs) by Types (2013-2018)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Growth Rate by Type (2013-2018)
Table United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales (K Pcs) by Application (2013-2018)
Table United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Application (2013-2018)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Application (2013-2018)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share by Application in 2017
Table United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Growth Rate by Application (2013-2018)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Growth Rate by Application (2013-2018)
Table Abgentis Limited Basic Information List
Table Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Sales Growth Rate (2013-2018)
Figure Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share in United States (2013-2018)
Figure Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share in United States (2013-2018)
Table AstraZeneca Plc Basic Information List
Table AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Sales Growth Rate (2013-2018)
Figure AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share in United States (2013-2018)
Figure AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share in United States (2013-2018)
Table Daiichi Sankyo Company Ltd Basic Information List
Table Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Sales Growth Rate (2013-2018)
Figure Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share in United States (2013-2018)
Figure Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share in United States (2013-2018)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Sales Growth Rate (2013-2018)
Figure Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Sales Market Share in United States (2013-2018)
Figure Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of DNA Gyrase Subunit B (EC 5.99.1.3)
Figure Manufacturing Process Analysis of DNA Gyrase Subunit B (EC 5.99.1.3)
Figure DNA Gyrase Subunit B (EC 5.99.1.3) Industrial Chain Analysis
Table Raw Materials Sources of DNA Gyrase Subunit B (EC 5.99.1.3) Major Players/Suppliers in 2017
Table Major Buyers of DNA Gyrase Subunit B (EC 5.99.1.3)
Table Distributors/Traders List
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Volume (K Pcs) Forecast by Type in 2025
Table United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Volume (K Pcs) Forecast by Application in 2025
Table United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Volume Share Forecast by Region (2018-2025)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Volume Share Forecast by Region (2018-2025)
Figure United States DNA Gyrase Subunit B (EC 5.99.1.3) Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications